Özgen Şafak

Dr. Özgen Şafak

MD
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2020 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
OAONUR ARGAN
ONUR ARGAN
EAEyup Avci
Eyup Avci
TYTarik Yildirim
Tarik Yildirim
ÖŞÖzgen Şafak
Özgen Şafak
Ascending aortic aneurysms are one of the major causes of mortality. In recent years, there is a growing interest of epicardial adipose tissue (EAT) and related diseases. The aim of this study was to investigate the relationship of EAT, and PAT with ascending aortic dilatation (AAD). We included 934 patients with hypertension in this study. The patients were evaluated by a complete transthoracic echocardiographic examination, including measurements of EAT, PAT, and aortic dimensions. Aortic size index (ASI) was used for diagnosing AAD. The patients were divided into two groups: dilated ascending aorta diameter (ASI ≥ 21 mm / m2, n = 102) or normal aortic diameter (ASI < 21 mm / m2, n = 832) according to the ASI. Characteristics of these patients were compared before and after propensity score matching analysis. Patients with AAD were older (72.3 ± 11.6 vs. 61.7 ± 12.7 years, p < 0.001), had more female gender (66% vs. 54%,p = 0.021) than patients with normal ascending aorta (AA). After propensity score matching analysis (77 vs. 77), EAT [OR:1.461, %95CI (1.082–1.974), p = 0.013] was independently associated with AAD in multivariate logistic regression analysis. In ROC curve analysis, EAT > 0.45 cm had 51.9% sensitivity and 62.3% specificity [AUC = 0.617, P = 0.012, 95% CI (0.529–0.707)]. Based on our findings, increased EAT may be suggested as an independent risk factor for AAD due to local or systemic effects in hypertensive patients.

18 September 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
ÖŞÖzgen Şafak
Özgen Şafak
MHMehmet Tolga Hekim
Mehmet Tolga Hekim
TÇTolga Çakmak
Tolga Çakmak
FDFatih Demir
Fatih Demir
KDKursat Demir
Kursat Demir
Background/Objectives: Cardiovascular diseases are among the leading causes of death worldwide. Early diagnosis of these conditions minimizes the risk of future death. Listening to heart sounds with a stethoscope is one of the easiest and fastest methods for diagnosing heart conditions. While heart sounds are a quick and easy diagnostic method, they require significant expert interpretation. Recently, artificial intelligence models trained based on these expert interpretations have become popular in the development of decision support systems. Methods: The proposed approach uses the popular 2016 PhysioNet/CinC Challenge dataset for PCG signals. Spectrogram image transformation was then performed to increase the representativeness of these signals. A deep learning-based model that allows for the simultaneous training of residual and attention blocks and the MLP-mixer model was used for feature extraction. A new algorithm combining the strengths of NCA and ReliefF algorithms was proposed to select the strongest features in the feature set. The SVM algorithm was used for classification. Results: With this proposed approach, over 98% success was achieved in all accuracy, sensitivity, specificity, precision, and F1-score metrics. Conclusions: As a result, an artificial intelligence-based decision support system that detects cardiovascular diseases with high accuracy is presented.

1 January 2019 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
ÖŞÖzgen Şafak
Özgen Şafak
Objective: Normal reference values for the cardiac chambers are widely based on cohorts from European or American populations. In this study, we aimed to obtain normal echocardiographic measurements of healthy Turkish volunteers to reveal the age, gender, and geographical region dependent differences between Turkish populations and other populations. Methods: Among 31 collaborating institutions from all regions of Turkey, 1154 healthy volunteers were enrolled in this study. Predefined protocols were used for all participants during echocardiographic examination. Blood biochemical parameters were also obtained for all patients on admission. The American Society of Echocardiography and European Association of Cardiovascular Imaging recommendations were used to assess the echocardiographic cardiac chamber quantification. Results: The study included 1154 volunteers (men: 609; women: 545), with a mean age of 33.5 +/- 11 years. Compared to men, women had a smaller body surface area, lower blood pressure and heart rate, lower hemoglobin, total cholesterol, lower low-density lipoprotein (LW levels, and higher high density lipoprotein (HOL) levels. Cardiac chambers were also smaller in women and their size varied with age. When we compared the regions in Turkey, the lowest values of left cardiac chamber indices were seen in the Marmara region and the highest values were observed in the Mediterranean region. Regarding the right cardiac indices, the Mediterranean region reported the lowest values, while the Black Sea region and the Eastern Anatolia region reported the highest values. Conclusion: This is the first study that evaluates the normal echocardiographic reference values for a healthy Turkish population. These results may provide important reference values that could be useful in routine clinical practice as well as in further clinical trials.

8 November 2024 in Journal Of Nephrology
Verified
Journal Article
Closed access
PDF file
ODOmer Dogan
Omer Dogan
AAAybike Gul Tasdelen Acar
Aybike Gul Tasdelen Acar
MGMural Gul
Mural Gul
ÖŞÖzgen Şafak
Özgen Şafak
SÖsefa ömür
sefa ömür
İEİbrahim Ersoy
İbrahim Ersoy
Background Acute kidney injury (AKI) is a common complication in chronic kidney disease (CKD) patients in the cardiac intensive care unit (cardiac ICU). In this study, we aimed to identify predictors of AKI in CKD patients treated in the cardiac ICU for cardiovascular diseases. Methods The MORCOR-TURK trial was conducted as a multicenter, prospective, cross-sectional, and noninterventional investigation. A total of 3157 patients treated in the cardiac ICU were enrolled from 50 centers over the course of one month. In this subgroup analysis, 615 patients with CKD treated in the cardiac ICU for cardiovascular disease were included in the study. The primary outcome of this study was the development of AKI. During hospitalization, patients who developed AKI were identified. Results AKI developed in 288 patients (46%). After multivariable analysis, decompensated heart failure (OR: 3.72, p = 0.005), primary percutaneous coronary intervention (OR: 3.75, p = 0.004), non-primary percutaneous coronary intervention (OR: 2.85, p = 0.033), troponin levels (OR: 1.04, p = 0.031), and need for mechanical ventilation (OR: 3.11, p < 0.001) were identified as independent predictors of AKI development in CKD patients. Conclusion Our efforts to identify AKI predictors in cardiac ICU patients with CKD have yielded directly applicable results in clinical practice. AKI can be prevented by developing personalized strategies to follow up and treat cardiac ICU patients with CKD who have decompensated heart failure, are undergoing percutaneous coronary intervention (primary and non-primary), have high troponin levels, and need mechanical ventilation. Graphical abstract

1 September 2016 in Coronary Artery Disease
Verified
Journal Article
Closed access
VDVolkan Dogan
Volkan Dogan
ÖBÖzcan Başaran
Özcan Başaran
OBOsman Beton
Osman Beton
MTMehmet Tekinalp
Mehmet Tekinalp
IBIsmail Bolat
Ismail Bolat
MBMurat Biteker
Murat Biteker
Nonvalvular atrial fibrillation (NVAF) frequently coexists with coronary artery disease (CAD). However, the optimal antithrombotic strategy for patients with concomitant CAD and NVAF is controversial. The aim of this study is to assess the prevalence of CAD with NVAF and to determine antithrombotic treatment options in patients with or without a history of CAD. ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in Turkey (RAMSES study) was a cross-sectional, multicenter, nationwide observational study carried out in NVAF patients. We studied the clinical data of 6264 Turkish patients participating in the RAMSES study. Demographic properties and antithrombotic therapies were recorded and compared between patients with and without CAD. CAD was present in 1828 (29.2%) of patients with NVAF. Most of the NVAF patients with CAD were men (58%) and comorbid diseases were significantly more common in patients with CAD. Although patients with CAD had higher CHA2DS2VASc scores than those without disease (4.1±1.5 vs. 2.9±1.5; P=0.001), they had lower use of oral anticoagulant (OAC) therapy (66.1 vs. 74.4%, P=0.01). Among OAC drugs, warfarin was the preferred medication in patients with CAD (35.4 vs. 30.6%, P=0.01), whereas nonvitamin K antagonist oral anticoagulants were preferred in patients without CAD (40 vs. 34.3%, P=0.01). Patients with CAD required nearly three-fold higher antiplatelet treatment compared with patients without CAD (57.8 vs. 21.4%, P<0.001). CAD affects nearly one-third of patients with NVAF in a real-world setting. Although they merit more aggressive therapy, patients with CAD and NVAF were less likely to receive OAC therapy.

27 June 2020 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
EAEyup Avci
Eyup Avci
TKTuncay Kırış
Tuncay Kırış
DADidar Elif Akgün
Didar Elif Akgün
Aykan ÇelikAykan Çelik
Aykan Çelik
FAFiliz Akyildiz-Akcay
Filiz Akyildiz-Akcay
AEAsim Oktay Ergene
Asim Oktay Ergene